Associate Professor Carter Cao, Ph.D., in the UNC Eshelman School of Pharmacy’s Division of Pharmacotherapy and Experimental Therapeutics, is harnessing the power of quantitative systems pharmacology (QSP) and cutting-edge computational modeling and simulation tools to understand how antibody-based treatments interact … Read more
Yanguang “Carter” Cao, Ph.D., has been promoted to associate professor with tenure in the UNC Eshelman School of Pharmacy’s Division of Pharmacotherapy and Experimental Therapeutics (DPET), effective Oct. 1. “I am extremely excited to move toward the next stage of … Read more
Yanguang “Carter” Cao, Ph.D., has received an R35 Outstanding Investigator Grant worth $1.85 million over five years from the National Institute of General Medical Sciences to create a platform to optimize antibody-based therapy. “Therapeutic antibodies have achieved great success in … Read more
